Literature DB >> 21168698

Epstein-Barr virus-associated hepatic leiomyosarcoma after renal transplantation: case report.

A Jeribi1, L Albano, M Berguignat, A Maaroufi, C Dewisme, G Favre, E Cassuto, M C Saint Paul, E Berard.   

Abstract

The incidence of neoplastic complications after solid organ transplantation is increasing tremendously probably as the consequence of long term immunosuppression. Beside usual risk factors, the oncogenic role of some viruses like Epstein-Barr virus is well established. We report a case of a primitive EBV-induced liver leiomyosarcoma after renal transplantation.
Copyright © 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21168698     DOI: 10.1016/j.transproceed.2010.09.122

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  4 in total

1.  Primary intracranial leiomyosarcoma of the torcular Herophili associated with Fanconi anemia and allogenic stem cell transplantation.

Authors:  Michèle Aumüller; Karl-Walter Sykora; Christian Hartmann; Elvis J Hermann; Joachim K Krauss
Journal:  Childs Nerv Syst       Date:  2014-04-22       Impact factor: 1.475

2.  Contemporary management and classification of hepatic leiomyosarcoma.

Authors:  Mazin O Hamed; Keith J Roberts; William Merchant; J Peter A Lodge
Journal:  HPB (Oxford)       Date:  2014-11-24       Impact factor: 3.647

Review 3.  Sarcomas other than Kaposi sarcoma occurring in immunodeficiency: interpretations from a systematic literature review.

Authors:  Kishor Bhatia; Meredith S Shiels; Alexandra Berg; Eric A Engels
Journal:  Curr Opin Oncol       Date:  2012-09       Impact factor: 3.915

4.  A Case of Epstein-Barr Virus-Associated Leiomyosarcoma Concurrently With Posttransplant Lymphoproliferative Disorders After Renal Transplantation.

Authors:  Naohiro Aida; Taihei Ito; Michihiro Maruyama; Kenichi Saigo; Naotake Akutsu; Hiromichi Aoyama; Hiroshi Kitamura; Takashi Kenmochi
Journal:  Clin Med Insights Case Rep       Date:  2019-07-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.